Kyle Serikawa works as a Project Manager in Type 1 Diabetes at the Benaroya Research Institute and also has a private consulting practice in genomics and enabling technologies. He is a recent graduate and current board member for Leadership Tomorrow in Seattle. After getting his undergraduate degree at Carleton College in Minnesota, Kyle realized he only likes snow in short, controlled bursts and moved to Berkeley for his PhD in Genetics and then to the University of Washington for his postdoctoral work, where he studied algal morphology of all things. In addition to his academic work, he has had the opportunity to work for Merck and Novo Nordisk. He has a strong interest in finding new and innovative ways to increase patient health.